Figure 5: Conolidine is antinociceptive in visceral, tonic and persistent ache models and is particularly existing at micromolar concentrations within the brain after systemic injection. Conolidine CONOCB2™ fundamentally will work by creating a barrier amongst the opioid receptors while in the brain and the "scavenger" receptors in the body, https://mileso813jfe8.wikicommunications.com/user